secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sensei Biotherapeutics, Inc. (SNSE)
CIK:        0001829802
Form:       8-K
Filed at:   2025-07-09T23:59:59+00:00
Accession:  0001193125-25-157113
Event type: regulatory
Sentiment:  positive
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Sensei Biotherapeutics regains Nasdaq minimum bid price compliance
------------------------------------------------------------------

- Received Nasdaq letter on July 2, 2025 confirming compliance with Rule 5550(a)(2).
- Closing bid price was at or above $1.00 for 10 consecutive business days (June 17 to July 1, 2025).
- No further action required; delisting risk removed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1829802/000119312525157113/0001193125-25-157113-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1829802/000119312525157113/d64284d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-157113

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer